[Site of action of efficacy of antisyphilitic treatment with penicillin. II. Problems of penicillin dosage].
D001665:Binding Sites; D003593:Cytoplasm; D003692:Delayed-Action Preparations; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006801:Humans; D046911:Macromolecular Substances; D010402:Penicillin G Procaine / Q000494:pharmacology; D010406:Penicillins / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology / Q000652:urine; D011220:Pralidoxime Compounds / Q000494:pharmacology; D011485:Protein Binding; D013587:Syphilis / Q000097:blood / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D013997:Time Factors; D014210:Treponema pallidum
D003692:Delayed-Action Preparations; D006634:Histamine H1 Antagonists; D046911:Macromolecular Substances; D010406:Penicillins; D011220:Pralidoxime Compounds; D010402:Penicillin G Procaine
Angriffspunkt und Wirksamkeit der antisyphilitischen Penicillinbehandlung. II. Die Problematik der Penicillindosierung.